Fraction of high-grade cervical intraepithelial lesions attributable to genotypes targeted by a nonavalent HPV vaccine in Galicia, Spain
Abstract Background Human papillomavirus (HPV) bivalent and quadrivalent vaccines have been widely implemented in worldwide organized immunization programs. A nonavalent HPV vaccine is now available in several countries. The objective was to describe the fraction of squamous non-invasive high-grade...
Main Authors: | S. Perez, A. Iñarrea, R. Pérez-Tanoira, M. Gil, E. López-Díez, O. Valenzuela, M. Porto, L. Alberte-Lista, M. A. Peteiro-Cancelo, A. Treinta, R. Carballo, M. C. Reboredo, M. E. Alvarez-Argüelles, M. J. Purriños |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-11-01
|
Series: | Virology Journal |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12985-017-0879-1 |
Similar Items
-
Correction to: Fraction of high-grade cervical intraepithelial lesions attributable to genotypes targeted by a nonavalent HPV vaccine in Galicia, Spain
by: S. Perez, et al.
Published: (2018-03-01) -
Potential impact of a nonavalent HPV vaccine on HPV related low-and high-grade cervical intraepithelial lesions: A referral hospital-based study in Sicily
by: Giuseppina Capra, et al.
Published: (2017-08-01) -
Estimating the epidemiological impact and cost-effectiveness profile of a nonavalent HPV vaccine in Spain
by: Jesús De La Fuente, et al.
Published: (2019-08-01) -
Estimation of the individual residual risk of cervical cancer after vaccination with the nonavalent HPV vaccine
by: Karl-Ulrich Petry, et al.
Published: (2018-07-01) -
A prospective, single-arm, open-label, non-randomized, phase IIa trial of a nonavalent prophylactic HPV vaccine to assess immunogenicity of a prime and deferred-booster dosing schedule among 9–11 year-old girls and boys – clinical protocol
by: Yi Zeng, et al.
Published: (2019-04-01)